Search research articles
Contact Us
Filters
Showing results (61-70 of 106) with videos related to
Page
of 11
Sort By:
Arthritis Research & Therapy
|
July 18, 2024
Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study
Panagiota Xanthouli, Paul Uesbeck, Hanns-Martin Lorenz, et al.
Arthritis Research & Therapy
|
June 19, 2015
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Christian Nagel, Philipp Henn, Nicola Ehlken, et al.
Arthritis Research & Therapy
|
July 21, 2022
Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis
Panagiota Xanthouli, Julia Miazgowski, Nicola Benjamin, et al.
Rheumatology and Therapy
|
November 26, 2025
Long-term Effectiveness and Safety of Canakinumab in Patients with TRAPS: Analysis of the RELIANCE Non-Interventional Study
Norbert Blank, Catharina Schuetz, Markus Hufnagel, et al.
Zeitschrift Fur Rheumatologie
|
December 12, 2024
Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still's disease in Germany : Implications for clinical practice in rheumatology
Rhea Friedrich, Anna Kernder, Norbert Blank, et al.
Annals of the Rheumatic Diseases
|
May 20, 2015
Activated human B cells induce inflammatory fibroblasts with cartilage-destructive properties and become functionally suppressed in return
Hannah Störch, Birgit Zimmermann, Bastian Resch, et al.
Respiratory Research
|
November 10, 2018
Right heart size and function significantly correlate in patients with pulmonary arterial hypertension - a cross-sectional study
Lukas Fischer, Nicola Benjamin, Norbert Blank, et al.
Annals of the Rheumatic Diseases
|
May 15, 2020
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
Claudia Kedor, Joachim Listing, Jan Zernicke, et al.
Rheumatology (Oxford, England)
|
April 22, 2024
Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission
Manuel Röhrich, Juan J Rosales, Jorge Hoppner, et al.
Rheumatology (Oxford, England)
|
December 16, 2015
Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome
Jasmin B Kuemmerle-Deschner, Ferdinand Hofer, Theresa Endres, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 106) with videos related to
Sort By:
Page
of 11
Arthritis Research & Therapy
|
July 18, 2024
Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study
Panagiota Xanthouli, Paul Uesbeck, Hanns-Martin Lorenz, et al.
Arthritis Research & Therapy
|
June 19, 2015
Stress Doppler echocardiography for early detection of systemic sclerosis-associated pulmonary arterial hypertension
Christian Nagel, Philipp Henn, Nicola Ehlken, et al.
Arthritis Research & Therapy
|
July 21, 2022
Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis
Panagiota Xanthouli, Julia Miazgowski, Nicola Benjamin, et al.
Rheumatology and Therapy
|
November 26, 2025
Long-term Effectiveness and Safety of Canakinumab in Patients with TRAPS: Analysis of the RELIANCE Non-Interventional Study
Norbert Blank, Catharina Schuetz, Markus Hufnagel, et al.
Zeitschrift Fur Rheumatologie
|
December 12, 2024
Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still's disease in Germany : Implications for clinical practice in rheumatology
Rhea Friedrich, Anna Kernder, Norbert Blank, et al.
Annals of the Rheumatic Diseases
|
May 20, 2015
Activated human B cells induce inflammatory fibroblasts with cartilage-destructive properties and become functionally suppressed in return
Hannah Störch, Birgit Zimmermann, Bastian Resch, et al.
Respiratory Research
|
November 10, 2018
Right heart size and function significantly correlate in patients with pulmonary arterial hypertension - a cross-sectional study
Lukas Fischer, Nicola Benjamin, Norbert Blank, et al.
Annals of the Rheumatic Diseases
|
May 15, 2020
Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
Claudia Kedor, Joachim Listing, Jan Zernicke, et al.
Rheumatology (Oxford, England)
|
April 22, 2024
Fibroblast activation protein inhibitor-positron emission tomography in aortitis: fibroblast pathology in active inflammation and remission
Manuel Röhrich, Juan J Rosales, Jorge Hoppner, et al.
Rheumatology (Oxford, England)
|
December 16, 2015
Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome
Jasmin B Kuemmerle-Deschner, Ferdinand Hofer, Theresa Endres, et al.
Page
of 11